INmune Bio Inc. has executed a warrant inducement offer letter and an amendment to common stock purchase warrants with holders of its April 2024 warrants. The company is offering holders the chance to exercise 50% of their warrants at a reduced price of $1.40 per share, down from $1.95. In exchange for exercising these warrants, the maturity date for the remaining 50% of the warrants will be extended from June 30, 2026, to December 31, 2027. Approximately 647,112 warrants are expected to be exercised, generating about $905,957 in cash for the company. The shares underlying these warrants are covered by an effective registration statement.